Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Finished Goods (2020 - 2025)

Maxcyte (MXCT) has disclosed Finished Goods for 6 consecutive years, with $3.2 million as the latest value for Q4 2025.

  • Quarterly Finished Goods fell 18.97% to $3.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2025, down 18.97% year-over-year, with the annual reading at $3.2 million for FY2025, 18.97% down from the prior year.
  • Finished Goods for Q4 2025 was $3.2 million at Maxcyte, down from $3.3 million in the prior quarter.
  • The five-year high for Finished Goods was $6.0 million in Q1 2024, with the low at $2.3 million in Q2 2021.
  • Average Finished Goods over 5 years is $3.8 million, with a median of $3.5 million recorded in 2025.
  • The sharpest move saw Finished Goods skyrocketed 121.46% in 2023, then crashed 40.19% in 2025.
  • Over 5 years, Finished Goods stood at $2.5 million in 2021, then grew by 16.25% to $2.9 million in 2022, then surged by 103.99% to $6.0 million in 2023, then crashed by 34.3% to $3.9 million in 2024, then fell by 18.97% to $3.2 million in 2025.
  • According to Business Quant data, Finished Goods over the past three periods came in at $3.2 million, $3.3 million, and $3.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.